Verde Bio Holdings, Inc. (APHD) Stock Price & Analysis
Verde Bio Holdings, Inc. (APHD) rose 0.00% to USD 1.7 as of July 25, 2026 at 09:04 UTC, according to Nexqual real-time market data.
APHD last closed at USD 1.7; the session ranged USD 1.7–1.7 on volume of 100 shares. Market capitalization is $30.78M, with a 52-week range of USD 0–4.98 (OID). Source: Nexqual, July 25, 2026 at 09:04 UTC.
Key Statistics (as of July 25, 2026 at 09:04 UTC)
| Price | USD 1.7 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 1.7 |
| Open | USD 1.7 |
| Day Range | USD 1.7 – 1.7 |
| 52-Week Range | USD 0 – 4.98 |
| Volume | 100 shares |
| Market Cap | $30.78M |
| Exchange | OID |
Technical Analysis (APHD)
Nexqual's technical model rates APHD "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 09:04 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.66 (neutral) |
| vs SMA50 | Above (USD 1.5) |
| MACD | -0.08 (negative) |
Analyst Ratings (APHD)
Wall Street analysts rate APHD "None", per Nexqual as of July 25, 2026 at 09:04 UTC.
| Consensus Rating | None |
|---|
Earnings (APHD)
Source: Nexqual, July 25, 2026 at 09:04 UTC.
Financials & Fundamentals (APHD)
| Total Revenue | $456,036 |
|---|---|
| Revenue Growth (YoY) | +171.50% |
| Gross Margin | -20.22% |
| Operating Margin | -69.89% |
| Profit Margin | +0.00% |
| Current Ratio | 0.1 |
| Total Cash | $126,016 |
| Total Debt | $0 |
| Free Cash Flow | $193,747 |
Source: Nexqual, July 25, 2026 at 09:04 UTC.
Financial Health Score (APHD)
Nexqual rates Verde Bio Holdings, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 09:04 UTC.
| Growth | Strong — Revenue +172% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $126K cash, no debt |
| Cash Flow | Strong — FCF $194K, 42% margin |
| Efficiency | Mixed — No data |
Ownership (APHD)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 18.10M |
Source: Nexqual, July 25, 2026 at 09:04 UTC.
Leadership (APHD)
Verde Bio Holdings, Inc. is led by Mark Newman, Chief Executive Officer, per Nexqual as of July 25, 2026 at 09:04 UTC.
| Chief Executive Officer | Mark Newman |
|---|---|
| Chief Financial Officer | Jerald Crowser |
| Chief Operating Officer | Rob Koch |
Major Backers & Investors (APHD)
Notable institutional backers of Verde Bio Holdings, Inc. include FRANK FUNDS-Camelot Event Driven Fund, according to Nexqual as of July 25, 2026 at 09:04 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FRANK FUNDS-Camelot Event Driven Fund | 0.28% |
Source: Nexqual, July 25, 2026 at 09:04 UTC.
From Verde Bio Holdings, Inc.'s Latest SEC 10-K Filing (filed 2023-08-02)
Key Strengths & Strategy (as disclosed to the SEC)
- Apogee 21 Holdings, Inc. doing business as A21 Wine & Spirits, produces and markets craft spirits and wine.
- The company owns Monkey in Paradise Vodka, Andale Tequila, and Blue Nectar Tequila brands.
- The company also has the sales agency for Zunte Mezcal, and Finca Ferrer Wines from Argentina.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AKVA | ARKANOVA ENERGY COMPANY | USD 0 | ▲ 0% |
| BRYN | Bryn Resources, Inc. | USD 0 | ▲ 0% |
| BLUU | BLUE WATER GLOBAL GROUP INC | USD 0 | ▲ 0% |
| GSPE | GULFSLOPE ENERGY INC | USD 0 | ▲ 0% |
| AHFD | Active Health Foods, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 09:04 UTC. This page is informational and not investment advice.